{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T19:30:10Z","timestamp":1771875010751,"version":"3.50.1"},"reference-count":24,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[1997,6,1]],"date-time":"1997-06-01T00:00:00Z","timestamp":865123200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[1997,6,1]],"date-time":"1997-06-01T00:00:00Z","timestamp":865123200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology"],"published-print":{"date-parts":[[1997,6]]},"DOI":"10.1016\/s0300-483x(97)03661-5","type":"journal-article","created":{"date-parts":[[2002,7,25]],"date-time":"2002-07-25T11:43:01Z","timestamp":1027597381000},"page":"145-155","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":99,"title":["Evaluation of the toxicity of ISIS 2302, a phosphorothioate oligonucleotide, in a four-week study in cynomolgus monkeys"],"prefix":"10.1016","volume":"120","author":[{"given":"Scott P.","family":"Henry","sequence":"first","affiliation":[]},{"given":"Henry","family":"Bolte","sequence":"additional","affiliation":[]},{"given":"Carol","family":"Auletta","sequence":"additional","affiliation":[]},{"given":"Douglas J.","family":"Kornbrust","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/S0300-483X(97)03661-5_bib1","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1016\/S0960-894X(01)80555-2","article-title":"Efficient synthesis of antisense oligodeoxynucleotide phosphorothioates","volume":"4","author":"Andrade","year":"1994","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/S0300-483X(97)03661-5_bib2","series-title":"Antisense Research and Applications","first-page":"547","article-title":"Antisense oligonucleotides in inflammation research and therapeutics","author":"Bennett","year":"1993"},{"key":"10.1016\/S0300-483X(97)03661-5_bib3","doi-asserted-by":"crossref","first-page":"3530","DOI":"10.4049\/jimmunol.152.7.3530","article-title":"Inhibition of endothelial cell adhesion molecule expression with antisense oligonucleotides","volume":"152","author":"Bennett","year":"1994","journal-title":"J. Immunol."},{"key":"10.1016\/S0300-483X(97)03661-5_bib4","series-title":"Methods in Molecular Medicine: Antisense Therapeutics","first-page":"13","article-title":"Pharmacology of antisense therapeutic agents","author":"Bennett","year":"1996"},{"key":"10.1016\/S0300-483X(97)03661-5_bib5","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1038\/355564a0","article-title":"Selection of single-stranded DNA molecules that bind and inhibit human thrombin","volume":"355","author":"Bock","year":"1992","journal-title":"Nature"},{"key":"10.1016\/S0300-483X(97)03661-5_bib6","first-page":"239","article-title":"Cardiovascular effects of a phosphorotioate oligonucleotide with sequence antisense to p53in the conscious rhesus monkey","volume":"3","author":"Cornish","year":"1993","journal-title":"Pharmacol. Commun."},{"key":"10.1016\/S0300-483X(97)03661-5_bib7","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1146\/annurev.pa.36.040196.000543","article-title":"Progress in antisense oligonucleotide therapeutics","volume":"36","author":"Crooke","year":"1996","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/S0300-483X(97)03661-5_bib8","first-page":"3165","volume":"148","author":"Ember","year":"1992","journal-title":"Biological activity of synthetic analogs of C5a anaphylatoxin"},{"key":"10.1016\/S0300-483X(97)03661-5_bib9","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1089\/ard.1994.4.201","article-title":"Complement activation and hemodynamic changes following intravenous administration of phosphorothioate oligonucleotides in the monkey","volume":"4","author":"Galbraith","year":"1994","journal-title":"Antisense. Res. Dev."},{"key":"10.1016\/S0300-483X(97)03661-5_bib10","doi-asserted-by":"crossref","first-page":"3271","DOI":"10.1182\/blood.V81.12.3271.3271","article-title":"In vivo anticoagulant properties of a novel nucleotide-based thrombin inhibitor and demonstration of regional anticoagulation in extracorporeal circuits","volume":"81","author":"Griffin","year":"1993","journal-title":"Blood"},{"key":"10.1016\/S0300-483X(97)03661-5_bib11","first-page":"353","article-title":"Effects of ISIS 2302, a phosphorothioate oligonucleotide, on in vitro and in vivo coagulation parameters","volume":"11","author":"Henry","year":"1994","journal-title":"Pharm. Res."},{"key":"10.1016\/S0300-483X(97)03661-5_bib12","article-title":"Evaluation of the toxicity of ISIS 2302, a phosphorothioate oligonucleotide. 1. 4-week study in mice","author":"Henry","year":"1996","journal-title":"Antisense Nucleic Acid Drug Dev."},{"key":"10.1016\/S0300-483X(97)03661-5_bib13","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1146\/annurev.pa.34.040194.000313","article-title":"Complement activation and inhibition in myocardial in myocardial ischemia and reperfusion injury","volume":"34","author":"Homeister","year":"1994","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/S0300-483X(97)03661-5_bib14","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/S0022-3565(25)20340-8","article-title":"Antithrombotic and anticoagulant properties of synthetic polyanions: sulfated bis-aldonic acid amides","volume":"259","author":"Klauser","year":"1991","journal-title":"Pharm. Exp. Ther."},{"key":"10.1016\/S0300-483X(97)03661-5_bib15","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1055\/s-0038-1645196","article-title":"Development of MDL 28,050, a small stable antithrombin agent based on a functional domain of the leech protein, hirudin","volume":"63","author":"Krstenansky","year":"1990","journal-title":"Thromb. Haemost."},{"key":"10.1016\/S0300-483X(97)03661-5_bib16","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1038\/ki.1995.406","article-title":"Renal uptake of and 18-mer phosphorothioate oligonucleotide","volume":"48","author":"Oberbauer","year":"1995","journal-title":"Kidney Int."},{"key":"10.1016\/S0300-483X(97)03661-5_bib17","doi-asserted-by":"crossref","first-page":"17651","DOI":"10.1016\/S0021-9258(17)46749-4","article-title":"The structure of \u03b1-thrombin inhibited by a 15-mer single-stranded DNA aptamer","volume":"268","author":"Padmanabhan","year":"1993","journal-title":"J. Biol. Chem."},{"key":"10.1016\/S0300-483X(97)03661-5_bib18","first-page":"124","article-title":"Cell and tissue distribution of synthetic oligonucleotides in healthy and tumor-bearing nude mice","volume":"147","author":"Plenat","year":"1995","journal-title":"Am. J. Pathol."},{"key":"10.1016\/S0300-483X(97)03661-5_bib19","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1089\/ard.1994.4.99","article-title":"In vivo toxicological effects of rel a antisense phosphorothioates in CD-1 mice","volume":"4","author":"Sarmiento","year":"1994","journal-title":"Antisense. Res. Dev."},{"key":"10.1016\/S0300-483X(97)03661-5_bib20","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/jcla.1860090210","article-title":"Review of in vivo pharmacokinetics and toxicology of phosphorothioate oligonucleotides","volume":"9","author":"Srinivasan","year":"1995","journal-title":"J. Clin. Lab. Anal."},{"key":"10.1016\/S0300-483X(97)03661-5_bib21","doi-asserted-by":"crossref","first-page":"5336","DOI":"10.4049\/jimmunol.153.11.5336","article-title":"Blocking of heart allograft rejection by intercellular adhesion molecule-1 antisense oligonucleotides alone or in combination with other immunosuppressive modalities","volume":"153","author":"Stepkowski","year":"1994","journal-title":"J. Immunol."},{"key":"10.1016\/S0300-483X(97)03661-5_bib22","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/0049-3848(93)90004-8","article-title":"In vivo pharmacology of aprosulate, a new synthetic polyanion with anticoagulant activity","volume":"69","author":"Sugidachi","year":"1993","journal-title":"Thrombosis Res."},{"key":"10.1016\/S0300-483X(97)03661-5_bib23","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1159\/000463207","article-title":"Adverse effects of clinical intervention on the complement system","volume":"8","author":"Svehag","year":"1991","journal-title":"Complement Inflamm."},{"key":"10.1016\/S0300-483X(97)03661-5_bib24","doi-asserted-by":"crossref","first-page":"24408","DOI":"10.1016\/S0021-9258(18)35781-8","article-title":"Localization of the single-stranded DNA binding site in the thrombin anionbinding exosite","volume":"267","author":"Wu","year":"1992","journal-title":"J. Biol. Chem."}],"container-title":["Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300483X97036615?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300483X97036615?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T22:43:41Z","timestamp":1759531421000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0300483X97036615"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,6]]},"references-count":24,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1997,6]]}},"alternative-id":["S0300483X97036615"],"URL":"https:\/\/doi.org\/10.1016\/s0300-483x(97)03661-5","relation":{},"ISSN":["0300-483X"],"issn-type":[{"value":"0300-483X","type":"print"}],"subject":[],"published":{"date-parts":[[1997,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of the toxicity of ISIS 2302, a phosphorothioate oligonucleotide, in a four-week study in cynomolgus monkeys","name":"articletitle","label":"Article Title"},{"value":"Toxicology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S0300-483X(97)03661-5","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 1997 Published by Elsevier Ireland Ltd.","name":"copyright","label":"Copyright"}]}}